Arrhythmogenic mortality in heart-transplant candidates.
Sudden cardiac death represents a major problem in patients awaiting heart transplantation (HTx). A retrospective analysis of 1019 patients accepted for HTx revealed a high actuarial risk for sudden death accounting to 14% after 1 year and 20% after 2 years waiting time. Underlying disease and hemodynamic characteristics had no predictive value. The use of implantable cardioverter/defibrillator therapy is discussed.
Fieguth
H G
HG
Division of Cardiovascular Surgery, Hannover Medical School, Germany.
Wahlers
T
T
Trappe
H J
HJ
Borst
H G
HG
D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000401:mortality*; D003645:Death, Sudden / Q000209:etiology; D017147:Defibrillators, Implantable; D016027:Heart Transplantation; D006801:Humans; D008875:Middle Aged; D012189:Retrospective Studies